Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which anesthesia is best for a calmer Wake-Up after septoplasty?

NCT ID NCT07304206

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at three different anesthesia methods to see which one causes less agitation when patients wake up from septoplasty (nose surgery). The methods tested were total intravenous anesthesia, combined inhaled and intravenous anesthesia, and inhaled anesthesia alone. Only 3 adults completed the study, so the results are very limited.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sevoflurane, propofol, remifentanil
What this could lead to
If successful, this could help identify which anesthesia method causes less confusion and agitation after nose surgery.
What could go wrong
This is a very small completed trial with only 3 participants, so results may not apply to larger groups. The findings are preliminary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

3 people

The number who actually took part.

Started

Dec 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 50 years old. * American Society of Anesthesiologists (ASA) Physical Status Class I or II. * Scheduled for elective septoplasty surgery. * Scheduled to receive general anesthesia Exclusion Criteria: * History of revision septoplasty * Known allergy to nonsteroidal anti-inflammatory drugs (NSAIDs) or the study drugs * History of bleeding disorder * History of allergy * ASA Physical Status greater than III * Body Mass Index (BMI) $\> 30 * History of hypertension, cardiovascular diseases, or cerebrovascular diseases * History of renal dysfunction * Use of psychiatric medications * History of substance abuse * Patients who refuse to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Emergence agitation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Emergence Delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Inonu University

    Malatya, 44250, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.